Asymptomatic Elevation of Amylase and Lipase

Common Etiologies

Asymptomatic elevations of amylase and lipase do not require withholding treatment or extensive workup in most cases, as they are commonly encountered in various non-pancreatic conditions and rarely indicate clinically significant pancreatitis, according to the National Comprehensive Cancer Network 1
Asymptomatic elevations in IBD patients found in 7% specifically for lipase 2
Immune checkpoint inhibitors commonly cause asymptomatic pancreatic enzyme elevations, and the National Comprehensive Cancer Network guidelines state that asymptomatic elevations do not require withholding ICIs in most cases 1
Routine monitoring of amylase or lipase in asymptomatic patients on immunotherapy is not recommended 3

Elevations less than 3 times the upper limit of normal have low specificity and should not trigger imaging without clinical correlation 4
Development of epigastric, right upper quadrant, or back pain warrants further evaluation 5
Persistently elevated levels beyond 10 days increase pseudocyst formation risk 5
Rising trends on serial measurements indicate potential underlying pathology 5

Lipase is more specific than amylase for pancreatic pathology and should be the preferred test 6
Lipase has 79% sensitivity and 89% specificity versus amylase's 72% sensitivity and 93% specificity for acute pancreatitis 6
CT scan with IV contrast is first-line imaging when investigation is warranted 5
MRCP serves as second-line non-invasive imaging 5

Normal enzyme levels do not exclude pancreatic injury if clinically suspected 5
Serum levels are neither sensitive nor specific within 3-6 hours after potential pancreatic injury 5
Lipase can remain elevated 8-14 days after initial pancreatic injury without indicating active pathology 6
Diagnosis of acute pancreatitis requires at least two of three criteria: characteristic abdominal pain, enzymes >3 times upper limit of normal, and consistent imaging findings 6

Serum enzyme estimation for diagnosing pancreatic insufficiency is hampered by the fact that pancreatic disease must be very advanced before serum enzyme concentrations become significantly reduced, and in patients with pancreatic insufficiency, abnormally low serum enzymes were found in only 50% of cases, according to the European Society of Gastrointestinal Endoscopy 7, 8
Serum enzyme quantification is therefore not of value in the diagnosis of chronic pancreatitis, as stated by the European Society of Gastrointestinal Endoscopy, with a substantial proportion of patients with marked functional impairment having normal serum enzyme levels 7, 8

Lipase alone is sufficient and more cost-effective than ordering both amylase and lipase tests when testing is clinically indicated, with lipase offering higher sensitivity (79% vs 72%) and a larger diagnostic window than amylase, according to the American Gastroenterological Association 9